- Home
- TBPH vs SNDL Comparison
TBPH vs SNDL Comparison
Compare TBPH & SNDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TBPH
- SNDL
- Stock Information
- Founded
- TBPH 2013
- SNDL 2006
- Country
- TBPH United States
- SNDL Canada
- Employees
- TBPH N/A
- SNDL 2604
- Industry
- TBPH Biotechnology: Pharmaceutical Preparations
- SNDL Pharmaceuticals and Biotechnology
- Sector
- TBPH Health Care
- SNDL Health Care
- Exchange
- TBPH Nasdaq
- SNDL Nasdaq
- Market Cap
- TBPH 699.0M
- SNDL 638.2M
- IPO Year
- TBPH N/A
- SNDL 2019
- Fundamental
- Price
- TBPH $13.95
- SNDL $2.48
- Analyst Decision
- TBPH Strong Buy
- SNDL Strong Buy
- Analyst Count
- TBPH 3
- SNDL 1
- Target Price
- TBPH $21.33
- SNDL $5.00
- AVG Volume (30 Days)
- TBPH 602.7K
- SNDL 5.2M
- Earning Date
- TBPH 08-12-2025
- SNDL 11-04-2025
- Dividend Yield
- TBPH N/A
- SNDL N/A
- EPS Growth
- TBPH N/A
- SNDL N/A
- EPS
- TBPH 0.26
- SNDL N/A
- Revenue
- TBPH $77,205,000.00
- SNDL $692,339,389.00
- Revenue This Year
- TBPH $78.36
- SNDL $5.52
- Revenue Next Year
- TBPH N/A
- SNDL $4.09
- P/E Ratio
- TBPH $54.52
- SNDL N/A
- Revenue Growth
- TBPH 24.49
- SNDL 3.54
- 52 Week Low
- TBPH $7.88
- SNDL $1.15
- 52 Week High
- TBPH $14.55
- SNDL $2.74
- Technical
- Relative Strength Index (RSI)
- TBPH 71.41
- SNDL 65.18
- Support Level
- TBPH $13.66
- SNDL $2.37
- Resistance Level
- TBPH $14.55
- SNDL $2.62
- Average True Range (ATR)
- TBPH 0.46
- SNDL 0.14
- MACD
- TBPH -0.02
- SNDL -0.01
- Stochastic Oscillator
- TBPH 56.20
- SNDL 63.38
About TBPH Theravance Biopharma Inc.
Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).
About SNDL SNDL Inc.
SNDL Inc is a private-sector liquor and cannabis retailer in Canada with retail banners that include Ace Liquor, Wine and Beyond, Liquor Depot, Value Buds, and Spiritleaf. The principal activities of the company are the retailing of wines, beers, and spirits. It comprised four reportable segments: liquor retail, cannabis retail, cannabis operations, and investments. Liquor retail includes the sale of wines, beers, and spirits through owned liquor stores. The company generates maximum revenue from liquor retail.